SynGenSys Introduces Liver.SET Synthetic Promoter Library for Liver-specific Gene Expression for in vivo Gene Therapies
SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch of its Liver.SET™ library of liver-specific synthetic promoters. Developed using SynGenSys’ proprietary informatics and computational design platform, the Liver.SET library comprises a range of compact, patentable synthetic promoters for liver-targeted gene expression for in vivo gene therapies.
SynGenSys Introduces NK.SET Synthetic Promoter Library to Advance Natural Killer Cell Therapies
SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch of NK.SET™. Developed using the Company’s proprietary informatics and design workflow, NK.SET is a synthetic promoter library designed to enable precise, tuneable gene expression in natural killer (NK) cell immunotherapies, to improve both efficacy and targeting.
